New Results
Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs
View ORCID ProfileKale Kundert, James E. Lucas, Kyle E. Watters, Christof Fellmann, Andrew H. Ng, Benjamin M. Heineike, Christina M. Fitzsimmons, Benjamin L. Oakes, David F. Savage, Hana El-Samad, Jennifer A. Doudna, Tanja Kortemme
doi: https://doi.org/10.1101/323105
Kale Kundert
1Graduate Group in Biophysics, University of California San Francisco, San Francisco, CA, USA
James E. Lucas
2UC Berkeley – UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA
Kyle E. Watters
3Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA
Christof Fellmann
3Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA
Andrew H. Ng
2UC Berkeley – UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA
Benjamin M. Heineike
4Bioinformatics Graduate Program, University of California San Francisco, San Francisco, CA, USA
Christina M. Fitzsimmons
5Chemistry and Chemical Biology Graduate Program, University of California San Francisco, San Francisco, CA, USA
Benjamin L. Oakes
3Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA
David F. Savage
3Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA
Hana El-Samad
6Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
7Chan Zuckerberg Biohub, San Francisco, CA, USA
Jennifer A. Doudna
3Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA
8Howard Hughes Medical Institute, University of California Berkeley, Berkeley, CA, USA
Tanja Kortemme
7Chan Zuckerberg Biohub, San Francisco, CA, USA
9Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA
Article usage
Posted May 15, 2018.
Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs
Kale Kundert, James E. Lucas, Kyle E. Watters, Christof Fellmann, Andrew H. Ng, Benjamin M. Heineike, Christina M. Fitzsimmons, Benjamin L. Oakes, David F. Savage, Hana El-Samad, Jennifer A. Doudna, Tanja Kortemme
bioRxiv 323105; doi: https://doi.org/10.1101/323105
Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs
Kale Kundert, James E. Lucas, Kyle E. Watters, Christof Fellmann, Andrew H. Ng, Benjamin M. Heineike, Christina M. Fitzsimmons, Benjamin L. Oakes, David F. Savage, Hana El-Samad, Jennifer A. Doudna, Tanja Kortemme
bioRxiv 323105; doi: https://doi.org/10.1101/323105
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14179)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16802)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)